Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Breast Neoplasms 2 Vascular Malformations 1 Solid Tumor 1 Skin Diseases, Vascular 1 Ovarian Neoplasms 1 Meningioma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Arteriovenous Malformations 1

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 5 Specimen Handling 4 Proton Therapy 3 Everolimus 3 pembrolizumab 2 gallium Ga 68 dotatate 2 abemaciclib 2 Sunitinib 2 Radiosurgery 2 Protons 2 Observation 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Elasticity Imaging Techniques 2 Bevacizumab 2 trametinib 1 regorafenib 1 olaparib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 auricularum 1 apatinib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631953 2024-08-06

ALTREM

Assistance Publique Hopitaux De Marseille

Phase 1 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡